Welcome
Ordering and Supplemental Information
Proficiency Testing/EQA
Quality Management Tools
Learning
Publications

Welcome

Please log in to determine if you are eligible to purchase PT Programs.
INFECTIOUS DISEASE, RESPIRATORY PANEL - IDR
IDR
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte Challenges per Shipment Number of Shipments
Adenovirus 5 Three shipments per year
Bocavirus 5
Bordetella (pertussis, parapertussis, bronchiseptica, holmesii) 5
Chlamydia pneumoniae 5
Coronavirus 5
Human metapneumovirus (HMPV) 5
Influenza A 5
Influenza B 5
Legionella pneumophilia 5
Mycoplasma pneumoniae 5
Parainfluenza 5
Respiratory syncytial virus (RSV) 5
Rhinovirus/Enterovirus 5
SARS-CoV-2* 5

Additional Information

  • *SARS-CoV-2 specimens do not contain human genomic nucleic acid or human RNase P gene.
  • For programs that include more than one subspecialty of microbiology, per CLIA, your laboratory is required to test five specimens, three times a year, for each subspecialty your laboratory performs.

Program Information

  • Five 1.0-mL liquid specimens
  • Designed for molecular multiplex panel users

Shipping Schedule

  • Shipment A: February 23
  • Shipment B: June 29
  • Shipment C: November 16






Guest

Log in/Register

Customers Who Bought This Item Also Bought
H5N1 INFLUENZA A DETECTION AND SUBTYPING
VIEW DETAILS >